Pharmacokinetics of parenteral and oral melperone in man

@article{Borgstrm2004PharmacokineticsOP,
  title={Pharmacokinetics of parenteral and oral melperone in man},
  author={Lars Borgstr{\"o}m and Hans Larsson and Lars Molander},
  journal={European Journal of Clinical Pharmacology},
  year={2004},
  volume={23},
  pages={173-176}
}
SummaryThe pharmacokinetics of melperone (Buronil®, Ferrosan, Sweden) was studied after administration of various parenteral and oral doses to man. After parenteral administration, the data could be fitted to a two-compartment model, but after oral dosing the distribution phase could not be separated from the elimination phase, and so an one-compartment model gave the best fit. The half-lives were about 3–4 h, except after intramuscular injection, when the half-life was about 6 h. The… 
9 Citations
Sedative effects and prolactin response to single oral doses of melperone
TLDR
The pharmacokinetics of melperone and the relationship between plasma concentration and the effect on arousal and prolactin secretion after single oral doses was studied and the possibility that reduced arousal reactions might contribute in the antipsychotic action of neuroleptic drugs was discussed.
Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
TLDR
Both formulations in the form of CR capsules and CR ODTs have shown suitability for progression into further clinical development, and are suitable for once-daily dosing.
Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic
TLDR
The relationship between plasma concentration and effect on arousal was studied in normal subjects after single oral and parenteral doses of melperone and a strong correlation was found when the effector compartment and central compartment were in equilibrium.
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
TLDR
Following the new guidelines for therapeutic drug monitoring in psychiatry holds the potential to improve neuropsychopharmacotherapy, accelerate the recovery of many patients, and reduce health care costs.
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
TLDR
Following guidelines for TDM in psychiatry will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems, and one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data.
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
TLDR
Authors C. Hiemke, N. Bergemann, H. Zurek, and G. Baumann write about life in the post-war period and the aftermath of the Second World War, as well as some of the events leading up to and during the conflict.
Comparison of two strategies for assessing ecotoxicological aspects of complex wastewater from a chemical-pharmaceutical plant
The potential environmental impact of wastewater from a chemical-pharmaceutical plant was evaluated by two different characterization strategies. The aim of the first strategy was to characterize the

References

SHOWING 1-10 OF 17 REFERENCES
Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.
TLDR
A mathematical equation is presented which enables one to determine the parameters identical to an i.v. bolus injection curve by utilizing the postinfusion blood curve, applicable to all compartmental models that may be described by linear first-order differential equations with constant coefficients.
Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women
TLDR
The results indicate that with the doses used thiothixene causes a more marked and long lasting blockade of central dopamine receptors controlling prolactin release, which is more potent and also more long acting than melperone.
Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients.
TLDR
The conclusion was that no serious side effects were observed which could with any certainty be related to melperone therapy.
Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients.
TLDR
The present study, which reports on the hitherto longest continuous melperone treatment recorded in the literature, did not find any severe side effects which could be related with any certainty tomelperone therapy.
A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS
TLDR
Treatment with both drugs was associated with significant reductions in morbidity as estimated by several measures of therapeutic effect from the CPRS, by the NOSIE scale and by global ratings.
A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase.
In a double-blind study in chronic alcoholics melperone (Buronil) was shown to significantly improve muscular and nervous tension, emotional lability, somatization, ability to sleep, anxiety,
Symbols in pharmacokinetics
TLDR
To encourage uniformity in the presentation of pharmacokinetic data, a general nomenclature has been developed and the symbols describing many common variables and constants are simple.
...
...